AEON Biopharma, Inc. Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The cumulative amount of the reporting entity's undistributed earnings or deficit.
-
Summary
-
AEON Biopharma, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2020 to Q2 2024.
- AEON Biopharma, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending June 30, 2024 was -$428M, a 3619% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)